FDA files motion to delay Endo litigation, again
February 07, 2019 at 12:59 PM EST
The pharmaceutical company is objecting to an FDA policy regarding bulk compounding.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|